Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Seminars in Cancer Biology|September 27, 2020
Limitations in resectability of colorectal liver metastases 2020 - A systematic approach for clinicians and patientsErik Schadde, Dirk J Grunhagen, Cornelis Verhoef, et al.
Cancer|December 3, 2005
The palliative value of tumor necrosis factor alpha-based isolated limb perfusion in patients with metastatic sarcoma and melanomaDirk J Grunhagen, Johannes H W de Wilt, Wilfried J Graveland, et al.
Cancer|March 17, 2006
Outcome and prognostic factor analysis of 217 consecutive isolated limb perfusions with tumor necrosis factor-alpha and melphalan for limb-threatening soft tissue sarcomaDirk J Grunhagen, Johannes H W de Wilt, Wilfried J Graveland, et al.
Oncoimmunology|October 25, 2019
Upregulation of intratumoral HLA class I and peritumoral Mx1 in ulcerated melanomasDaniëlle Verver, Vichnou Poirier-Colame, Gorana Tomasic, et al.
Diseases of the Colon and Rectum|February 9, 2013
Long-term results of the "liver first" approach in patients with locally advanced rectal cancer and synchronous liver metastasesNinos Ayez, Jacobus W A Burger, Anne E van der Pool, et al.
European Journal of Cancer (Oxford, England : 1990)|October 27, 2017
Elderly patients with gastrointestinal stromal tumour (GIST) receive less treatment irrespective of performance score or comorbidity - A retrospective multicentre study in a large cohort of GIST patientsSheima Farag, Frits van Coevorden, Esther Sneekes, et al.
Clinical & Experimental Metastasis|December 12, 2024
Molecular characterization of the histopathological growth patterns of colorectal cancer liver metastases by RNA sequencing of targeted samples at the tumor-liver interfaceEmily Latacz, Sanne M L Verheul, Yasmine Sillis, et al.
Annals of Surgery|February 15, 2022
A Nationwide Prospective Clinical Trial on Active Surveillance in Patients With Non-intraabdominal Desmoid-type Fibromatosis: The GRAFITI TrialAnne-Rose W Schut, Milea J M Timbergen, Danique L M van Broekhoven, et al.
European Journal of Cancer (Oxford, England : 1990)|March 27, 2026
Predictive value of [<sup>18</sup>F]FDG PET/CT and index lymph node response following neoadjuvant pembrolizumab in resectable stage 3 melanoma: Real world data from the largest melanoma centres in the NetherlandsMichael J Wilson, Antonius W Schurink, Yvonne Schrage, et al.
Cancer Medicine|March 3, 2025
Preoperative Inflammatory Status and Postoperative Morbidity in Patients With Primary Retroperitoneal SarcomaPia van der Laan, Fabio Tirotta, Stijn van der Burg, et al.
Pageof 3